NO991192L - Middel for behandling av prostatahypertrofi og prostatakreft - Google Patents
Middel for behandling av prostatahypertrofi og prostatakreftInfo
- Publication number
- NO991192L NO991192L NO991192A NO991192A NO991192L NO 991192 L NO991192 L NO 991192L NO 991192 A NO991192 A NO 991192A NO 991192 A NO991192 A NO 991192A NO 991192 L NO991192 L NO 991192L
- Authority
- NO
- Norway
- Prior art keywords
- prostate
- treatment
- hypertrophy
- prostate cancer
- cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2599096P | 1996-09-12 | 1996-09-12 | |
US4322897P | 1997-04-10 | 1997-04-10 | |
PCT/EP1997/004740 WO1998010781A1 (en) | 1996-09-12 | 1997-09-01 | Means for treating prostate hypertrophy and prostate cancer |
Publications (3)
Publication Number | Publication Date |
---|---|
NO991192D0 NO991192D0 (no) | 1999-03-11 |
NO991192L true NO991192L (no) | 1999-04-28 |
NO326207B1 NO326207B1 (no) | 2008-10-20 |
Family
ID=26700570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19991192A NO326207B1 (no) | 1996-09-12 | 1999-03-11 | Anvendelse av forbindelsen Cetrorelix for fremstilling av et middel for behandling av prostatahypertrofi og prostatakreft |
Country Status (29)
Country | Link |
---|---|
US (4) | US6054432A (no) |
EP (1) | EP0925069B1 (no) |
JP (1) | JP2001500500A (no) |
KR (1) | KR100546235B1 (no) |
CN (1) | CN1126566C (no) |
AR (1) | AR009757A1 (no) |
AT (1) | ATE370743T1 (no) |
AU (1) | AU738306B2 (no) |
BR (1) | BR9713197A (no) |
CA (1) | CA2215015A1 (no) |
CZ (1) | CZ298738B6 (no) |
DE (1) | DE69738045T2 (no) |
DK (1) | DK0925069T3 (no) |
EE (1) | EE04000B1 (no) |
ES (1) | ES2289764T3 (no) |
HK (1) | HK1021937A1 (no) |
HU (1) | HUP0000261A3 (no) |
IL (3) | IL128331A0 (no) |
IS (1) | IS4978A (no) |
MX (1) | MXPA99002420A (no) |
NO (1) | NO326207B1 (no) |
NZ (1) | NZ334540A (no) |
PL (1) | PL193184B1 (no) |
PT (1) | PT925069E (no) |
RU (1) | RU2215537C2 (no) |
SK (1) | SK286174B6 (no) |
TR (1) | TR199900556T2 (no) |
TW (1) | TWI224002B (no) |
WO (1) | WO1998010781A1 (no) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6828415B2 (en) * | 1993-02-19 | 2004-12-07 | Zentaris Gmbh | Oligopeptide lyophilisate, their preparation and use |
US6054432A (en) * | 1996-09-12 | 2000-04-25 | Asta Medica Aktiengesellschaft | Means for treating prostate hypertrophy and prostate cancer |
FR2768055A1 (fr) * | 1997-09-11 | 1999-03-12 | Synthelabo | Utilisation de derives de sulfonanilide pour obtenir un medicament destine au traitement de l'ejaculation retrograde ou de l'aspermie |
TW536402B (en) * | 1998-06-26 | 2003-06-11 | Yamanouchi Pharma Co Ltd | Pharmaceutical composition for the therapy of voiding dysfunction |
DE19911771B4 (de) * | 1999-03-17 | 2006-03-30 | Zentaris Gmbh | LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung |
US7105560B1 (en) | 1999-07-23 | 2006-09-12 | The Regents Of The University Of California | Use of etodolac in the treatment of multiple myeloma |
US7361680B2 (en) * | 1999-07-23 | 2008-04-22 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
US7129262B2 (en) * | 1999-07-23 | 2006-10-31 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
US7151100B1 (en) | 1999-07-23 | 2006-12-19 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
US6545034B1 (en) * | 1999-07-23 | 2003-04-08 | The Regents Of The University Of California | Use of etodolac for the treatment of chronic lymphocytic leukemia |
WO2001010436A1 (fr) * | 1999-08-09 | 2001-02-15 | Yamanouchi Pharmaceutical Co., Ltd. | Compositions medicinales destinees au traitement de l'uropathie inferieur |
DE60045751D1 (de) | 1999-09-30 | 2011-04-28 | Harbor Biosciences Inc | Therapeutische Behandlung androgenrezeptorbedingter Leiden |
US20040152672A1 (en) * | 2000-08-09 | 2004-08-05 | Carson Dennis A. | Indole compounds useful for the treatment of cancer |
KR100876538B1 (ko) * | 2000-08-17 | 2008-12-31 | 아에테르나 젠타리스 게엠베하 | Lhrh 길항제의 염의 제조방법 |
DE10040700A1 (de) * | 2000-08-17 | 2002-02-28 | Asta Medica Ag | Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung |
JP2001288115A (ja) * | 2001-02-07 | 2001-10-16 | Yamanouchi Pharmaceut Co Ltd | 下部尿路症治療剤 |
DE10137174A1 (de) * | 2001-07-31 | 2003-02-13 | Zentaris Ag | Verwendung von LHRH-Antagonisten in nichtkastrierenden Dosen zur Verbesserung der T-Zellen-vermittelten Immunität |
WO2004026116A2 (en) * | 2002-09-19 | 2004-04-01 | The Regents Of The University Of California | Use of etodoclac to treat hyperplasia |
GB0301016D0 (en) * | 2003-01-16 | 2003-02-19 | Univ London | Treatment of benign prostatic hyperplasia |
JP2006516571A (ja) | 2003-01-17 | 2006-07-06 | スレッシュオールド ファーマシューティカルズ, インコーポレイテッド | 良性前立腺増殖症の処置 |
BRPI0711280A2 (pt) * | 2006-05-03 | 2012-03-06 | Wisconsin Alumni Research Foundation | Métodos de reproduzir a concentração de espécies de oxigênio reativo na próstata de um ser humano do sexo masculino, de tratar profilaticamente câncer da próstata de um ser humano do sexo masculino, de tratar câncer na próstata de um ser humano do sexo masculino, de inibir acetil poliamina oxidase na prótata de um ser humano do sexo masculino, de determinar estresse oxidativo emn tecido humano, de tratar câncer na próstata de um cachorro, de reproduzir a concentração de espécies de oxigênio reativo em tecido humano, de usar o kit, e de determinar estresse oxidativo em tecido da próstata de ser humano do sexo masculino, composição farmacêutica oral, kit e reagentes para medir a concentração de espécies de oxigênio reativo ex vivo ou in vivo em uma célula, órgão, ou biópsia de mamífero |
EP1891964A1 (en) * | 2006-08-08 | 2008-02-27 | AEterna Zentaris GmbH | Application of initial doses of LHRH analogues and maintenance doses of LHRH antagonists for the treatment of hormone-dependent cancers and corresponding pharmaceutical kits |
EP1967202A1 (en) * | 2007-03-05 | 2008-09-10 | AEterna Zentaris GmbH | Use of LHRH Antagonists for the Treatment of Lower Urinary Tract Symptoms, in particular Overactive Bladder and/or Detrusor Overactivity |
EP2095818A1 (en) * | 2008-02-29 | 2009-09-02 | AEterna Zentaris GmbH | Use of LHRH antagonists at non-castrating doses |
US10585101B2 (en) | 2016-03-10 | 2020-03-10 | Wavesense, Inc. | Prostatic liquid biopsy for the detection of prostate cancer and benign prostatic hyperplasia |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU199694B (en) * | 1988-05-10 | 1990-03-28 | Innofinance Altalanos Innovaci | Process for producing citostatic pharmaceutical compositions containing gonadoliberin derivatives |
DE3918543A1 (de) * | 1989-06-07 | 1990-12-13 | Boehringer Mannheim Gmbh | Verwendung von naftopidil zur therapie der dysurie bei benigner prostata-hypertrophie |
IL101245A0 (en) * | 1991-03-20 | 1992-11-15 | Merck & Co Inc | Pharmaceutical compositions for the treatment of prostatic cancer |
US6054432A (en) * | 1996-09-12 | 2000-04-25 | Asta Medica Aktiengesellschaft | Means for treating prostate hypertrophy and prostate cancer |
-
1997
- 1997-08-07 US US08/908,198 patent/US6054432A/en not_active Expired - Fee Related
- 1997-09-01 EE EEP199900121A patent/EE04000B1/xx not_active IP Right Cessation
- 1997-09-01 PT PT97944818T patent/PT925069E/pt unknown
- 1997-09-01 KR KR1019997002053A patent/KR100546235B1/ko not_active IP Right Cessation
- 1997-09-01 PL PL332085A patent/PL193184B1/pl not_active IP Right Cessation
- 1997-09-01 IL IL12833197A patent/IL128331A0/xx unknown
- 1997-09-01 BR BR9713197-0A patent/BR9713197A/pt not_active Application Discontinuation
- 1997-09-01 ES ES97944818T patent/ES2289764T3/es not_active Expired - Lifetime
- 1997-09-01 RU RU99107280/14A patent/RU2215537C2/ru not_active IP Right Cessation
- 1997-09-01 AU AU46198/97A patent/AU738306B2/en not_active Ceased
- 1997-09-01 CZ CZ80899A patent/CZ298738B6/cs not_active IP Right Cessation
- 1997-09-01 JP JP10513204A patent/JP2001500500A/ja active Pending
- 1997-09-01 SK SK301-99A patent/SK286174B6/sk not_active IP Right Cessation
- 1997-09-01 EP EP97944818A patent/EP0925069B1/en not_active Expired - Lifetime
- 1997-09-01 TR TR1999/00556T patent/TR199900556T2/xx unknown
- 1997-09-01 AT AT97944818T patent/ATE370743T1/de not_active IP Right Cessation
- 1997-09-01 NZ NZ334540A patent/NZ334540A/xx unknown
- 1997-09-01 HU HU0000261A patent/HUP0000261A3/hu unknown
- 1997-09-01 WO PCT/EP1997/004740 patent/WO1998010781A1/en active IP Right Grant
- 1997-09-01 DE DE69738045T patent/DE69738045T2/de not_active Expired - Lifetime
- 1997-09-01 DK DK97944818T patent/DK0925069T3/da active
- 1997-09-01 CN CN97197904A patent/CN1126566C/zh not_active Expired - Fee Related
- 1997-09-01 MX MXPA99002420A patent/MXPA99002420A/es unknown
- 1997-09-10 TW TW086113121A patent/TWI224002B/zh active
- 1997-09-10 CA CA002215015A patent/CA2215015A1/en not_active Abandoned
- 1997-09-11 AR ARP970104168A patent/AR009757A1/es not_active Application Discontinuation
-
1998
- 1998-04-09 US US09/057,458 patent/US5998377A/en not_active Expired - Fee Related
- 1998-04-20 US US09/062,704 patent/US6071882A/en not_active Expired - Fee Related
-
1999
- 1999-02-02 IL IL128331A patent/IL128331A/en not_active IP Right Cessation
- 1999-02-16 IS IS4978A patent/IS4978A/is unknown
- 1999-03-11 NO NO19991192A patent/NO326207B1/no not_active IP Right Cessation
- 1999-09-22 US US09/401,851 patent/US6300313B1/en not_active Expired - Fee Related
-
2000
- 2000-02-11 HK HK00100793A patent/HK1021937A1/xx not_active IP Right Cessation
-
2008
- 2008-01-30 IL IL189132A patent/IL189132A0/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO991192D0 (no) | Middel for behandling av prostatahypertrofi og prostatakreft | |
NO994069D0 (no) | Forbindelser for immunoterapi av prostatacancer og fremgangsmåte for anvendelse derav | |
NO971015D0 (no) | Forbindelser og metoder for behandling av cancer | |
NO984229D0 (no) | Forbindelser og fremgangsmÕter for immunoterapi og immunodiagnose av prostatakreft | |
NO20004098L (no) | FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser | |
NO991955D0 (no) | FremgangsmÕte for behandling av hydrokarboner | |
ATE239509T1 (de) | Konjugate zur behandlung von prostatakrebs | |
NO20015516D0 (no) | Preparater og anvendelser av ET743 for behandling av kreft | |
NO20012963D0 (no) | Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler | |
NO20002189L (no) | Anvendelse av makrolider for behandling av cancer og mukuladegenerasjon | |
IS5056A (is) | Ný meðhöndlun á liðbólgu | |
IS5035A (is) | Aðferðir til varnar gegn brjóstakrabbameini | |
NO983512D0 (no) | Midler for behandling og forhindring av AIDS | |
NO994631D0 (no) | Fremgangsmaater og sammensetninger for behandling av eggstokkreft | |
ID19542A (id) | Pengobatan baru | |
NO20001758D0 (no) | Fremgangsmåter og blandinger for behandling av leddgikt | |
ATE250580T1 (de) | Substituierte pyridino-arylpiperazine zur behandlung benigner prostatahyperplasie | |
NO961113D0 (no) | Behandling og forebyggelse av prostatakreft | |
NO985068D0 (no) | Vaksiner for behandling av lymfom og leukemi | |
NO992561D0 (no) | Oppslemmingsbehandlingssystem og oppslemmingsbehandlingsmetode | |
AU7130696A (en) | Combination of beta-interferon for the treatment of prostate cancer | |
ZA978162B (en) | Means for treating prostate hypertrophy and prostate cancer. | |
AU4402497A (en) | Methods and means for the treatment of malignancies | |
GB9828564D0 (en) | Materials and methods for the treatment and diagnosis of cancer | |
SI0925069T1 (sl) | Uporaba Cetrorelix-a za zdravljenje benigne hipertrofije prostate in prostatnega raka |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |